AnaBios
![](https://i0.wp.com/3rc.org/wp-content/uploads/2024/03/ANABIOS-LOGO-F.jpg?fit=450%2C195&ssl=1)
AnaBios aims to establish the safety and efficacy of novel compounds through its advanced, human-focused translational technologies, including superior quality human tissue samples and functional assays focused, as well as human primary cells through its subsidiary Cell Systems.
Ossiform
![](https://i0.wp.com/3rc.org/wp-content/uploads/2023/04/Logo@4xOSSIFORM.jpg?fit=800%2C212&ssl=1)
Ossiform provides scaffold-based bioceramic 3D cell culture systems that mimic the architecture and complexity of calcified bone tissue. The scaffolds are made from a nonpolymeric bioink consisting solely of β-TCP.
BiomimX
![](https://i0.wp.com/3rc.org/wp-content/uploads/2022/01/Screen-Shot-2022-01-18-at-3.18.40-PM.png?fit=575%2C253&ssl=1)
BiomimX develops the next generation of beating organs-on-chips. uBeat® Platforms and connected hardware provide 3D miniaturized constructs with a tunable mechanical stimulation to model human organs’ function and diseases. uBeat® products and customized drug screening services are available.
Alcyomics
![](https://i0.wp.com/3rc.org/wp-content/uploads/2021/08/Alcyomics-Perfect-Size.png?fit=800%2C336&ssl=1)
Alcyomics is a pre-clinical service provider using Skimune®, non-artificial human skin explants to predict adverse immune reactions of novel compounds. The Skimune® platform also assess the efficacy of monoclonal antibodies, immune inhibitors and safety of cellular therapies.